跳至主要内容
临床试验/JPRN-UMIN000021841
JPRN-UMIN000021841招募中未知

Clinical trial of concurrent chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in patients with locally advanced head and neck squamous cell carcinoma - Clinical trial of concurrent chemoradiotherapy with TPF regimen in patients with locally advanced HNSCC

Yokohama City University hospital0 个研究点目标入组 50 人开始时间: 2016年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. History of the serious hypersensitivity for drugs used in this trial 2. The needs to use phenytoin or warfarin potassium during this trial. 3. 24-h creatinine clearance <65 ml/min 4. Active infection 5. Active digestive tract disorder 6. Evidence of interstinal lung disease, or pulmonary fibrosis 7. Evidence of uncontrolled diabetes mellitus 8. Evidence of uncontrolled cardiovascular disease 9. Severe hepatic dysfunction 10. Severe watery diarrhea 11. Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 12. Physician concludes that the patient&#39;s participation in this trial is inappropriate

研究者

相似试验

Clinical trial of concurrent chemoradiotherapy with... | 临床试验